Medicine
Volume 37, Issue 10 , Pages 518-521, October 2009

The immunocompromised patient: primary immunodeficiencies

A David B Webster MD FRCP FRCPath is an Honorary Clinical Scientist in the UCL Centre for Primary Immunodeficiency (Royal Free Campus), London, UK. Conflict of interest: none declared

Abstract 

The field of primary immunodeficiency diseases (PID) has grown dramatically over the past 10 years, the number of defined genetic causes almost doubling to a current total of about 130 different defects. These often are very rare disorders which have taught us much about the crucial cellular pathways required for protection against infection from a wide variety of microbes. Although most clinicians do not need a detailed knowledge of the different types of PID, they should be aware of the possibility of PID in patients presenting with recurrent or persistent infection, and be able to refer patients to a regional specialized clinic for immunodeficiency. A general understanding of which components of the immune system protect against different infections makes the diagnostic process more interesting and rewarding. Because many of the more severe PIDs present in infancy or childhood, paediatricians should have some special training in the area so that they know which patients require urgent referral to an expert centre. There have been some landmark recent advances in the management of severe PIDs, particularly in the technology of bone marrow transplantation and gene therapy where complete cures have been achieved.

Keywords: bacterial infection, bone marrow transplantation, complement deficiencies, fungal infection, gene therapy, hypogammaglobulinaemia, immunoglobulin therapy, lymphocyte defects, neutropenia, phagocyte defects, primary immunodeficiency, viral infection

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(09)00210-2

doi:10.1016/j.mpmed.2009.07.006

Medicine
Volume 37, Issue 10 , Pages 518-521, October 2009